GEHC (GE HealthCare Technologies) YoY EBITDA Growth: 11.64% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GEHC GE HealthCare Technologies Inc GEHC
76 GF Score
Price $69.72
GF Value $84.39
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies YoY EBITDA Growth?

GE HealthCare Technologies GEHC -1.19% 76 YoY EBITDA Growth is 11.64% as of Jun. 2026. GuruFocus rates GEHC with a GF Score™ of 76/100 and a GF Value™ of $84.39 (Modestly Undervalued). The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. GE HealthCare Technologies's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 11.64%.

GE HealthCare Technologies's EBITDA per Share for the three months ended in Jun. 2026 was $2.13.

GE HealthCare Technologies YoY EBITDA Growth Related Terms

GE HealthCare Technologies YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for GE HealthCare Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GE HealthCare Technologies YoY EBITDA Growth Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial 3.94 -8.58 7.77 4.13 3.49

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 -2.66 -0.97 -19.26 11.64
GEHC
76GF Score
GE HealthCare Technologies Inc GEHC
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GE HealthCare Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

GE HealthCare Technologies's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(8.266-7.987)/ | 7.987 |
=3.49 %

GE HealthCare Technologies's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(2.13-1.908)/ | 1.908 |
=11.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 11.64% mean?
GE HealthCare Technologies (GEHC) has a YoY EBITDA Growth of 11.64% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for GE HealthCare Technologies and its competitors.
Is GE HealthCare Technologies' YoY EBITDA Growth too high?
GE HealthCare Technologies' current YoY EBITDA Growth is 11.64%. Overall, GE HealthCare Technologies has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' YoY EBITDA Growth compare to DXCM and STE?
GE HealthCare Technologies' YoY EBITDA Growth of 11.64% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for GE HealthCare Technologies and its competitors. GE HealthCare Technologies's current YoY EBITDA Growth is 11.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $84.39, compared to a current price of $69.72 — trading 17.4% below its estimated fair value. The current YoY EBITDA Growth is 11.64%. GE HealthCare Technologies' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For GE HealthCare Technologies (GEHC), the current YoY EBITDA Growth is 11.64% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (GEHC) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of $69.72 is trading 17.4% below its estimated GF Value™ of $84.39. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for GEHC:

  • YoY EBITDA Growth: 11.64%
  • GF Value™: $84.39 vs. price of $69.72 (17.4% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
76GF Score

Get the complete analysis for GEHC

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$69.72
Price
$84.39
GF Value